A Phase I, Open-label Study to Assess the Safety and Efficacy of Poly-ICLC Plus Nivolumab in Unresectable Hepatocellular Carcinoma Patients
Clinical trial NCT05281926 · UNKNOWN
Trial details
- NCT number
- NCT05281926
- Sponsor
- National Taiwan University Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2024-06-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.